Pipeline

Indications

Myasthenia Gravis (MG)
MG is a rare, chronic autoimmune disorder characterized by weakness and fatigue of voluntary muscles. The clinical course of MG is variable but usually progressive, and patients tend to experience fluctuating symptoms. There is an estimated prevalence of 18 cases of MG per 100,000 people in the United States. For women, disease onset typically occurs around their 20s and 30s, whereas for men it peaks in their 50s and 60s. Overall, MG affects women more frequently than men.

The disease is most often caused by autoantibodies that target the acetylcholine receptor or muscle-specific tyrosine kinase receptor at the neuromuscular junction, disrupting normal muscular function. Symptoms typically emerge in the eyes (e.g., drooping eyelids, double vision, blurred vision) and progress into the face, throat, or limbs. Some patients may experience life-threatening respiratory complications due to the weakening of muscles involved in respiration.

Thyroid Eye Disease (TED)
TED, also known as Graves’ Ophthalmopathy, is an autoimmune disorder affecting the tissues around the eyes. It is a progressive and clinically variable disease that can become debilitating, disfiguring, or sight-threatening. The incidence of TED in the United States is approximately 10 per 100,000.

TED can be caused by IgG autoantibodies that form against the thyroid-stimulating hormone receptor (TSHR). These antibodies, which also cause Graves’ disease, target the extraocular space and result in clinical manifestations of the disease. Common signs of disease include proptosis (eye bulging), tearing, periorbital edema (swelling around the eyes), dry eyes, and pain behind the eyes; in severe cases, double vision or vision loss may occur.

Chronic Inflammatory Demyelinated Polyneuropathy (CIDP)
CIDP is an autoimmune neurological disorder characterized by damage to the myelin sheaths or the nodes on nerve fibers of the peripheral nervous system. Though the clinical presentation of CIDP is diverse, it can be categorized into monophasic, relapsing-remitting, or chronic progressive disease. CIDP is a rare disease that can occur in any age group and affects men twice as much as women. Its prevalence is estimated to be approximately 9 per 100,000 people in the United States.

CIDP appears to be mediated by IgG antibodies that are directed against myelin or proteins at the node of Ranvier; however, the specific target of these antibodies is not yet established. The hallmark signs of CIDP are weakness, tingling sensations, or loss of sensation in the arms and legs that is symmetrical and gradually worsens.

Graves’ Disease
Graves’ Disease is an autoimmune disorder associated with the overproduction of thyroid hormones and is the most common cause of hyperthyroidism. Although Graves’ Disease can affect any age group or gender, it is most prevalent in women younger than 40 years of age with its prevalence estimated at 35 per 100,000 in the United States.

The disease is mediated by thyroid-stimulating IgG antibodies that cause the thyroid gland to produce an excess of thyroid hormones, resulting in systemic manifestations that affect multiple organs. Patients typically present with classic signs and symptoms of hyperthyroidism, such as heat intolerance, weight loss, anxiety, and frequent bowel movements. The disease can also manifest with ophthalmopathy (e.g., eye redness, swelling, bulging) or dermopathy. If left untreated, patients not only experience the unpleasant impact of elevated thyroid hormones, but also may develop arrhythmias, heart failure, or life-threatening thyroid storms.